Pancrelipase (marketed as Creon) Information
FDA has approved pancrelipase (Creon Delayed-Release Capsules) for adult and pediatric patients with exocrine pancreatic insufficiency (EPI) due to cystic fibrosis (CF), chronic pancreatitis, and other conditions.
PDF requires the free Adobe Acrobat Reader
Date created: May 1, 2009 |